|
ZFP64 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.0187999999477E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.89919996080357E-09 |
| Normal-vs-Stage2 |
3.505500E-02 |
| Normal-vs-Stage3 |
9.154200E-02 |
| Normal-vs-Stage4 |
5.893900E-02 |
| Stage1-vs-Stage2 |
4.378000E-01 |
| Stage1-vs-Stage3 |
7.639900E-04 |
| Stage1-vs-Stage4 |
8.895800E-02 |
| Stage2-vs-Stage3 |
2.816400E-01 |
| Stage2-vs-Stage4 |
6.133000E-01 |
| Stage3-vs-Stage4 |
5.361800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.34560000003759E-06 |
| Normal-vs-AfricanAmerican |
4.076000E-02 |
| Normal-vs-Asian |
9.81159999999814E-05 |
| Caucasian-vs-AfricanAmerican |
6.999600E-01 |
| Caucasian-vs-Asian |
1.343840E-01 |
| AfricanAmerican-vs-Asian |
1.409960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.54839999999945E-05 |
| Normal-vs-Female |
1.75504999999632E-05 |
| Male-vs-Female |
4.775200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.455990E-02 |
| Normal-vs-Age(41-60Yrs) |
2.42939999994807E-06 |
| Normal-vs-Age(61-80Yrs) |
2.827300E-04 |
| Normal-vs-Age(81-100Yrs) |
9.743000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.377800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.873010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.528100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.611000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.943900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.011810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.05979999998063E-06 |
| Normal-vs-Grade 2 |
1.31899999999963E-06 |
| Normal-vs-Grade 3 |
4.172300E-04 |
| Normal-vs-Grade 4 |
2.335600E-01 |
| Grade 1-vs-Grade 2 |
3.390500E-02 |
| Grade 1-vs-Grade 3 |
3.571900E-02 |
| Grade 1-vs-Grade 4 |
2.957500E-03 |
| Grade 2-vs-Grade 3 |
1.816250E-01 |
| Grade 2-vs-Grade 4 |
7.456300E-02 |
| Grade 3-vs-Grade 4 |
3.212600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.31890000038193E-07 |
| Normal-vs-ccB subtype |
5.89819999999852E-05 |
| ccA subtype-vs-ccB subtype |
9.839400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65747999999466E-05 |
| Normal-vs-N1 |
1.407620E-01 |
| N0-vs-N1 |
8.678600E-01 |
|
|
